Does inhibition of aromatase by the specific inhibitor letrozole radiosensitize human breast cancer cells in vitro?

被引：0
|
作者：
Schmid-Bielenberg, D. [1 ]
Ohneseit, P. A. [1 ]
Krebiehl, G. [1 ]
Rodemann, H. P. [1 ]
机构：
[1] Sekt Strahlenbiol & Mol Umweltforsch, Tubingen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2006年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [1] Letrozole: A new aromatase inhibitor for metastatic breast cancer
    Mays-Holland, T
    [J]. CANCER PRACTICE, 1998, 6 (06) : 349 - 352
  • [2] Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
    Neville-Webbe, H. L.
    Coleman, R. E.
    Holen, I.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (06) : 1010 - 1017
  • [3] Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
    H L Neville-Webbe
    R E Coleman
    I Holen
    [J]. British Journal of Cancer, 2010, 102 : 1010 - 1017
  • [4] Mammalian target of rapamycin (mTOR) as a target in human breast cancer cells that have acquired resistance to aromatase inhibitor letrozole
    Sabnis, Gauri J.
    Jelovac, Danijela
    Long, Brian J.
    Schayowitz, Adam
    Belosay, Aashvini
    Brodie, Angela M. H.
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [5] Advanced breast cancer: Prognostic and predictive factors for the aromatase inhibitor Letrozole
    Possinger, K
    Wischnewsky, MB
    Bohm, R
    Chaudri, HA
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 14 - 15
  • [6] The aromatase inhibitor letrozole restores FADS2 function in ER+MCF7 human breast cancer cells
    Park, Hui Gyu
    Kim, Jae Hun
    Dancer, Andrew N.
    Kothapalli, Kumar S.
    Brenna, J. Thomas
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2021, 171
  • [7] Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients
    Generali, Daniele
    Bates, Gaynor
    Berruti, Alfredo
    Brizzi, Maria P.
    Campo, Leticia
    Bonardi, Simone
    Bersiga, Alessandra
    Allevi, Giovanni
    Milani, Manuela
    Aguggini, Sergio
    Dogliotti, Luigi
    Banham, Alison H.
    Harris, Adrian L.
    Bottini, Alberto
    Fox, Stephen B.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (03) : 1046 - 1051
  • [8] Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model
    Long, BJ
    Jelovac, D
    Handratta, V
    Thiantanawat, A
    MacPherson, N
    Ragaz, J
    Goloubeva, OG
    Brodie, AM
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (06) : 456 - 465
  • [9] Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole
    Miller, William R.
    Larionov, Alexey A.
    Renshaw, Lorna
    Anderson, Thomas J.
    White, Sharon
    Murray, Juliette
    Murray, Emma
    Hampton, Garret
    Walker, John R.
    Ho, Steven
    Krause, Andreas
    Evans, Dean B.
    Dixon, John Michael
    [J]. PHARMACOGENETICS AND GENOMICS, 2007, 17 (10): : 813 - 826
  • [10] Early Breast Cancer in Elderly Women Treated with an Aromatase Inhibitor (Letrozole) as Sole Therapy
    Balakrishnan, A.
    Ravichandran, D.
    [J]. CANCER RESEARCH, 2010, 70
12345